Boehringer Ingelheim
@boehringer
Join the conversation on the latest in healthcare innovation from Boehringer Ingelheim HQ. #LifeForward
Community Guidelines: bit.ly/TWguideline-
ID: 17437735
https://b-i.news/socialtermstw 17-11-2008 08:55:11
15,15K Tweet
106,106K Followers
3,3K Following
#NEWS: We are excited to expand our partnership with OSE Immunotherapeutics - Biotechs & immunothérapie to develop novel first-in-class treatments for cancer and cardio-renal-metabolic (CRM) diseases. Learn more: bit.ly/3V9fWmn #CardioMetabolic #Cancer #ResearchAndDevelopment
#NEWS There is an imperative need to address the barriers around perception and gaps in care for mental health conditions, such as schizophrenia. Find out more in this new report from Economist Impact on how to ensure better care for every mind:
#NEWS: We look forward to working with AUROBAC THERAPEUTICS to develop a first-in-class septic shock treatment. AUROBAC is growing its pipeline focused on severe infections in acute hospital settings. Learn more: bit.ly/3yL3PDt #AMR #ResearchCollaboration
#NEWS: We're taking a big step forward in our mission to transform cancer care. Our first-in-class SIRPα immuno-oncology program, initiated by OSE Immunotherapeutics - Biotechs & immunothérapie, is moving to the next clinical stage. Learn more: bit.ly/4cHPzd8 #Cancer #ImmunoOncology #ResearchAndDevelopment
#NEWS: With our new biomass power plant in Ingelheim we're producing more #sustainable energy for our site 💚 The inauguration took place today with the German Vice Chancellor Robert #Habeck Bundesministerium für Wirtschaft und Klimaschutz. 👉 bit.ly/3zrMek4
We’ve discovered a way to potentially treat #KRAS-driven #cancer more effectively and delay the onset of drug resistance using a drug combination. This research published in Nature Cancer was done in collaboration with MD Anderson Cancer Center. Learn more here: go.nature.com/3LVzi9i